Voyager Therapeutics Names Alfred Sandrock, Jr CEO, Succeeding Michael Higgins

Voyager Therapeutics, Inc. (VYGR), a gene therapy company, announced Tuesday the appointment of Alfred Sandrock, Jr. as chief executive officer. Sandrock succeeds Michael Higgins, who served as interim CEO since June 2021, and continues to serve as Chairman of the Voyager Board of Directors.

Sandrock was appointed to the Voyager Board of Directors in February 2022, following 23 years at Biogen where he identified and developed novel therapies for a variety of serious diseases.

He served as chief medical officer at Biogen and was ultimately appointed head of research and development.

Higgins said, "His success pioneering the development of numerous innovative neurological treatments, and particularly, his skill in advancing promising candidates from early-stage research toward clinical proof of concept, is perfectly suited for Voyager. He is the ideal leader to amplify the impact of our proprietary TRACERTM AAV capsids that we believe can overcome many of the limitations of first-generation AAV gene therapy and create meaningful therapeutics for patients."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Retailers Macy's, Inc. (M) and Dollar General Corp. (DG) reported on Thursday that net profits for the first quarter declined from last year, with Macy's topping estimates, while Dollar General missed it. Net sales at both retailers missed expectations. Both Macy's and Dollar General also slashed their guidance for the full-year 2023. The U.S. Food and Drug Administration has warned certain retailers against unauthorized sales of popular disposable e-cigarettes, mainly various types of Puff and Hyde brand e-cigarettes. Under the retailer inspection blitz, warning letters have been issued to 30 retailers, including one distributor, for illegally selling such products. All products cited in the warning letters are disposable Tillamook County Creamery Association is recalling a limited quantity of family-size 1.5qt cartons of Tillamook Waffle Cone Swirl ice cream due to undeclared wheat and soy, known allergens, the U.S. Food and Drug Administration said. The Tillamook Waffle Cone Swirl ice cream was mistakenly packaged in a Tillamook Chocolate Peanut Butter ice cream carton.
Follow RTT